Active ingredientBromperidolCat. No. P-B123-001CAS 10457-90-6Family · Pharmaceutical analytical standards
Bromperidol
A typical antipsychotic of the butyrophenone family, discovered in 1966 and used to treat schizophrenia, also as a long-acting depot injection (bromperidol decanoate). This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is a 'twin' of haloperidol: the two molecules differ by a single atom, a bromine in place of the chlorine on the aromatic ring, hence the name.
Go to the active ingredient →Active ingredientBromperidolCat. No. P-B123-001CAS 10457-90-6
Isotopically labelledBromperidol-d4Cat. No. P-B123-002CAS 1216919-75-3
ImpurityBromperidol DecanoateCat. No. P-B123-003CAS 75067-66-2
ImpurityBromperidol Decanoate HydrochlorideCat. No. P-B123-004CAS 83863-75-6No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceBromperidol CRSEDQM code B1152000Family BromperidolReference substanceBromperidol decanoate CRSEDQM code B1152050Family BromperidolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.